In comparison, when mice received supportive IL-2, and Non-Td, CoStAR-Td, or TCR-Td T cells, mice reached their tumor volume limits by days 52, 76, and 55, respectively (Figure 4A). The gene discussed is IL2; the disease is neoplasm.